Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Additions at Gyros, Healthtell

Premium

Gyros this week appointed Claus Braestrup to its board of directors.

Braestrup was previously president and CEO at H. Lundbeck. He also held executive positions at Novo Nordisk and Schering. He currently holds board seats at Bavarian Nordic, Probiodrug, Santaris Pharma, and Evolva Holding.


Healthtell has named David Smith vice president of operations.

Smith previously held senior leadership positions at biotech firms including Affymetrix, 454 Life Sciences, and Codon Devices.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.